The latest myeloma news
Cancer vaccine shows promise for multiple myeloma in small trial
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe…
Browsing: Myeloma
New insights to enhance treatment and diagnosis of blood cancer
A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
Potent oral agent that acts as both immunotherapy and targeted treatment produces high response rate in patients with hard-to-treat and refractory multiple myeloma when combined with steroid
A new agent that subverts myeloma cells from within while also subjecting them to an…
Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine,…
Adding immunity to human kidney-on-a-chip advances cancer drug testing
A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new…
European Commission approves reduced dosing frequency of teclistamab for multiple myeloma
The European Commission (EC) has granted the approval of a type II variation application for…
Blood cancer therapy granted accelerated FDA approval
The US Food and Drug Administration (FDA) has given the green light to Elrexfio™ (elranatamab-bcmm),…
Novel bispecific antibodies talquetamab and teclistamab receives positive CHMP opinions for the treatment of relapsed and refractory multiple myeloma
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)…
Digital comparator trial shows five-drug combo can keep ultra-high-risk myelomas in remission for longer
Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at…
Study brings new understanding of multiple myeloma evolution
A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights…